Effects of opiate receptor blockade with naloxone on thyrotropin secretion in heart transplant patients. 1996

J Gumprecht, and M Zembala, and E Zukowska-Szczechowska, and W Grzeszczak, and Z Religa, and D Moczulski, and J Wojarski
Department of Internal and Occupational Diseases, Silesian School of Medicine, Zabrze, Poland.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013972 Thyrotropin A glycoprotein hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Thyrotropin stimulates THYROID GLAND by increasing the iodide transport, synthesis and release of thyroid hormones (THYROXINE and TRIIODOTHYRONINE). Thyrotropin consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the pituitary glycoprotein hormones (TSH; LUTEINIZING HORMONE and FSH), but the beta subunit is unique and confers its biological specificity. Thyroid-Stimulating Hormone,TSH (Thyroid Stimulating Hormone),Thyreotropin,Thyrotrophin,Hormone, Thyroid-Stimulating,Thyroid Stimulating Hormone
D013973 Thyrotropin-Releasing Hormone A tripeptide that stimulates the release of THYROTROPIN and PROLACTIN. It is synthesized by the neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, TRH (was called TRF) stimulates the release of TSH and PRL from the ANTERIOR PITUITARY GLAND. Protirelin,Thyroliberin,Abbott-38579,Antepan,Proterelin Tartrate,Proterelin Tartrate Hydrate,Protirelin Tartrate (1:1),Relefact TRH,Stimu-TSH,TRH Ferring,TRH Prem,Thypinone,Thyroliberin TRH Merck,Thyrotropin-Releasing Factor,Thyrotropin-Releasing Hormone Tartrate,Abbott 38579,Abbott38579,Hydrate, Proterelin Tartrate,Prem, TRH,Stimu TSH,StimuTSH,TRH, Relefact,Tartrate Hydrate, Proterelin,Thyrotropin Releasing Factor,Thyrotropin Releasing Hormone,Thyrotropin Releasing Hormone Tartrate

Related Publications

J Gumprecht, and M Zembala, and E Zukowska-Szczechowska, and W Grzeszczak, and Z Religa, and D Moczulski, and J Wojarski
February 1980, The Journal of clinical endocrinology and metabolism,
J Gumprecht, and M Zembala, and E Zukowska-Szczechowska, and W Grzeszczak, and Z Religa, and D Moczulski, and J Wojarski
July 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
J Gumprecht, and M Zembala, and E Zukowska-Szczechowska, and W Grzeszczak, and Z Religa, and D Moczulski, and J Wojarski
May 1994, The Journal of clinical endocrinology and metabolism,
J Gumprecht, and M Zembala, and E Zukowska-Szczechowska, and W Grzeszczak, and Z Religa, and D Moczulski, and J Wojarski
August 1996, Polskie Archiwum Medycyny Wewnetrznej,
J Gumprecht, and M Zembala, and E Zukowska-Szczechowska, and W Grzeszczak, and Z Religa, and D Moczulski, and J Wojarski
April 1982, Diabetes,
J Gumprecht, and M Zembala, and E Zukowska-Szczechowska, and W Grzeszczak, and Z Religa, and D Moczulski, and J Wojarski
March 1985, The American journal of physiology,
J Gumprecht, and M Zembala, and E Zukowska-Szczechowska, and W Grzeszczak, and Z Religa, and D Moczulski, and J Wojarski
October 1992, Polskie Archiwum Medycyny Wewnetrznej,
J Gumprecht, and M Zembala, and E Zukowska-Szczechowska, and W Grzeszczak, and Z Religa, and D Moczulski, and J Wojarski
January 1995, International journal of sports medicine,
J Gumprecht, and M Zembala, and E Zukowska-Szczechowska, and W Grzeszczak, and Z Religa, and D Moczulski, and J Wojarski
April 2004, Animal reproduction science,
J Gumprecht, and M Zembala, and E Zukowska-Szczechowska, and W Grzeszczak, and Z Religa, and D Moczulski, and J Wojarski
March 1994, Polskie Archiwum Medycyny Wewnetrznej,
Copied contents to your clipboard!